These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 25539569

  • 21. Comparison of visual field defects using matrix perimetry and standard achromatic perimetry.
    Patel A, Wollstein G, Ishikawa H, Schuman JS.
    Ophthalmology; 2007 Mar; 114(3):480-7. PubMed ID: 17123623
    [Abstract] [Full Text] [Related]

  • 22. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH, Hutchison DM, Nicolela MT, LeBlanc RP, Chauhan BC.
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Vigabatrin and epilepsy: lessons learned.
    Wild JM, Ahn HS, Baulac M, Bursztyn J, Chiron C, Gandolfo E, Safran AB, Schiefer U, Perucca E.
    Epilepsia; 2007 Jul; 48(7):1318-27. PubMed ID: 17635558
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
    Werth R, Schädler G.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
    [Abstract] [Full Text] [Related]

  • 32. Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity.
    Lawthom C, Smith PE, Wild JM.
    Ophthalmology; 2009 Mar; 116(3):565-71. PubMed ID: 19168223
    [Abstract] [Full Text] [Related]

  • 33. [Clinical experiences with the "Swedish interactive threshold algorithm" (SITA)].
    Remky A, Arend O.
    Klin Monbl Augenheilkd; 2000 Mar; 216(3):143-7. PubMed ID: 10773977
    [Abstract] [Full Text] [Related]

  • 34. Swedish interactive thresholding algorithm fast for following visual fields in prepubertal idiopathic intracranial hypertension.
    Stiebel-Kalish H, Lusky M, Yassur Y, Kalish Y, Shuper A, Erlich R, Lubman S, Snir M.
    Ophthalmology; 2004 Sep; 111(9):1673-5. PubMed ID: 15350321
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Vigabatrin and visual field defects in pediatric epilepsy patients.
    You SJ, Ahn H, Ko TS.
    J Korean Med Sci; 2006 Aug; 21(4):728-32. PubMed ID: 16891821
    [Abstract] [Full Text] [Related]

  • 37. Characteristics of a unique visual field defect attributed to vigabatrin.
    Wild JM, Martinez C, Reinshagen G, Harding GF.
    Epilepsia; 1999 Dec; 40(12):1784-94. PubMed ID: 10612345
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Modelling the topography of absolute defects in patients exposed to the anti-epileptic drug vigabatrin and in normal subjects using automated static suprathreshold perimetry of the entire 80° visual field.
    Besch D, Schiefer U, Eter N, Burth R, Elger CE, Spitznas M, Dietz K.
    Graefes Arch Clin Exp Ophthalmol; 2011 Sep; 249(9):1333-43. PubMed ID: 21380539
    [Abstract] [Full Text] [Related]

  • 40. [Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods].
    Riise P, Fledelius HC, Rogvi-Hansen Bà.
    Ugeskr Laeger; 2003 Mar 03; 165(10):1034-8. PubMed ID: 12645411
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.